Sunitibenz 50 Capsule
Marketer
Admac Pharma Ltd
Salt Composition
Sunitinib (50mg)
Overview Sunitibenz 50 Capsule
Sunitinib 50mg capsules treat kidney cancer and gastrointestinal stromal tumors by inhibiting enzymes that fuel cancer cell proliferation, thus reducing tumor size and growth rate. Administer this medication with or without food, maintaining consistent daily timing for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include fatigue, diarrhea, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring is often recommended. Hypoglycemia, potentially severe enough to cause fainting, is possible; diabetics should monitor blood glucose levels closely and discuss potential anti-diabetic dosage adjustments with their doctor. Prior to commencing treatment, disclose any pre-existing heart, liver, kidney, or bleeding disorders. Inform your healthcare provider of all other medications you are taking, as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.
Uses of Sunitibenz 50 Capsule
Kidney and gastrointestinal stromal tumor therapies
Major Benefits of Sunitibenz 50 Capsule:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Sunitibenz 50 Capsules. These capsules can be ingested with or without food, however, consistent timing is recommended.
Common Side effects of Sunitibenz 50 Capsule:
- Hand-foot syndrome
- Bleeding disorder
- Low blood platelets
- Decreased appetite
- Nausea
- Vomiting
- Weakness
- Abdominal pain
- Indigestion
- High blood pressure
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Taste change
How to use Sunitibenz 50 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sunitibenz 50 Capsules. These capsules can be ingested with or without food, however, consistent timing is recommended.
How Sunitibenz 50 Capsule works:
Sunitibenz 50 Capsules are an anticancer drug that inhibits the growth of cancerous tumors. This action is achieved by targeting and neutralizing tyrosine kinase, a cell surface protein crucial for cancer cell multiplication. The medication also suppresses angiogenesis, the formation of new blood vessels supplying the tumor, thus limiting cancer spread.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Sunitibenz 50 Capsule with alcohol is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Sunitibenz 50 Capsule during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Sunitibenz 50 Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Sunitibenz 50 Capsule, which can induce dizziness. Refrain from operating vehicles or machinery if dizziness occurs during treatment.
KidneySAFE IF PRESCRIBED
Sunitibenz 50 Capsules pose no safety concerns for individuals with kidney impairment; dosage modification is unnecessary.
LiverSAFE IF PRESCRIBED
Sunitibenz 50 Capsules may be administered to patients with hepatic impairment without the need for dosage modification.
What if you forget to take Sunitibenz 50 Capsule :
Omit any missed Sunitibenz 50 Capsule dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Sunitibenz 50 Capsule
| Label | Value |
|---|---|
| Type of Compound | Compounds derived from indole and pyrrole |
| Addictive | None. |
| Medication Classification | Cancer therapies |



